OBJECTIVE: To review and discuss the diagnostic and surgical therapeutic methods of adrenocortical @entity66 . METHODS: A retrospective analysis was done to 180 @entity1636 @entity1 (74 males, 109 females, aged 6~76 (average 40.1). Studies were done to the relationship between @entity1 ' clinical characteristics, biochemical, endocrinological and imaging examination results, the therapeutic effects. RESULTS: Among all 180 cases, there are 107 @entity4923 ( @entity4923 ), 19 ectopic adrenocorticotropin @entity774 (EAAH), 28 @entity29587 ( @entity29587 ), 4 @entity4922 ( @entity4922 ), and 28 @entity1368 ( @entity1368 ). Twenty-four-hour urinary free @entity701 (24 h UFC) excretion of @entity4923 , EAAH, @entity29587 and @entity4922 @entity1 were 95.2~535.7   g (average 287.6   g), 24.8~808.2   g (average 307.9   g), 102.5~3127.0   g (average 852.5   g), and 243.8~1124.6   g (average 564.3   g). Both low and high-dose @entity619 suppression tests (DDST) were not suppressed in @entity29587 , @entity4922 and EAAH groups, but HDDST was suppressed in @entity4923 group. CT thin scanning results of 180 @entity1 all showed enlargements in the affected side adrenal gland. Unilateral adrenalectomies were performed in 102 @entity699 cases. Local lesion excisions were done to 21 @entity1368 @entity1 . 57 @entity1 had surgeries in both sides of the adrenal glands (39 bilateral total adrenalectomies, 16 total adrenalectomy in one side andsubtotal adrenalectomy in the other, 2 bilateral subtotal adrenalectomies). 106 (59%) @entity1 were followed up for 4~158 (average 32) months. CONCLUSION: Unilateral adrenalectomy was the first choice for operable @entity1636 @entity1 . The operation mode for the other adrenal gland should be based on the type of @entity1373 and clinical observation.

Classification and surgical treatment for 180 cases of adrenocortical XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity66 :: ('MESH:D004194', 'Disease') :: ['hyperplastic disease'] @entity4922 :: ('MESH:C566469', 'Disease') :: ['PPNAH', 'primary pigmented nodular adrenocortical hyperplasia'] @entity1373 :: ('MESH:D006965', 'Disease') :: ['hyperplasia'] @entity4923 :: ('MESH:D047748', 'Disease') :: ['CD', 'Cushing disease'] @entity29587 :: ('MESH:C565662', 'Disease') :: ['adrenocorticotropin independent macronodular adrenal hyperplasia', 'AIMAH'] @entity699 :: ('MESH:D003480', 'Disease') :: ['hypercortisolism'] @entity619 :: ('MESH:D003907', 'Chemical') :: ['dexamethasone'] @entity1636 :: ('MESH:D018268', 'Disease') :: ['adrenocortical hyperplasia'] @entity701 :: ('MESH:D006854', 'Chemical') :: ['cortisol'] @entity1368 :: ('MESH:D006929', 'Disease') :: ['IHA', 'Idiopathic Hyperaldosteronism'] @entity774 :: ('MESH:D000312', 'Disease') :: ['adrenal hyperplasia']
@entity66 :: (MESH:D004194,Disease) :: ['hyperplastic disease']
